Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.62 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.53 |
| ▸ | MAOA | P21397 | 1/20 | 0.47 |
| ▸ | MAOB | P27338 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | CA1 | P00915 | 9/20 | 0.42 |
| ▸ | CA2 | P00918 | 9/20 | 0.42 |
| ▸ | CA12 | O43570 | 6/20 | 0.42 |
| ▸ | CA9 | Q16790 | 6/20 | 0.42 |
| ▸ | STK17B | O94768 | 1/20 | 0.38 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.38 |
| ▸ | PAOX | Q6QHF9 | 2/20 | 0.37 |
| ▸ | DRD2 | P14416 | 1/20 | 0.36 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3472122 | 0.97 | CA14 (0.62) | CA14TDP1MAOAMAOBMEN1 | |
| SCHEMBL7264039 | 0.97 | CA14 (0.58) | CA14TDP1MAOAMAOBMEN1 | |
| SCHEMBL7270004 | 0.97 | CA14 (0.58) | CA14TDP1MAOAMAOBMEN1 | |
| SCHEMBL1919913 | 0.96 | CA14 (0.60) | CA14TDP1MAOAMAOBMEN1 | |
| SCHEMBL4370840 | 0.96 | CA14 (0.59) | CA14TDP1MAOAMAOBMEN1 | |
| SCHEMBL5919555 | 0.94 | CA14 (0.58) | CA14TDP1MAOAMAOBMEN1 | |
| SCHEMBL10181287 | 0.93 | CA14 (0.53) | CA14TDP1MAOAMAOBMEN1 | |
| SCHEMBL19340291 | 0.93 | CA14 (0.57) | CA14TDP1MAOAMAOBMEN1 | |
| SCHEMBL25238320 | 0.92 | CA14 (0.56) | CA14TDP1MAOAMAOBMEN1 | |
| SCHEMBL17396373 | 0.92 | CA14 (0.56) | CA14TDP1MAOAMAOBMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250388597-A1 | BIFUNCTIONAL PHOTOCROSSLINKING PROBES FOR COVALENT CAPTURE OF PROTEIN-NUCLEIC ACID COMPLEXES IN CELLS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2025-12-25 | — | — | US | disclosed |
| EP-4572795-A2 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS | The University of Chicago (US) | 2025-06-25 | — | — | EP | disclosed |
| EP-4554576-A2 | BIFUNCTIONAL PHOTOCROSSLINKING PROBES FOR COVALENT CAPTURE OF PROTEIN-NUCLEIC ACID COMPLEXES IN CELLS | University of Southern California (US) | 2025-05-21 | — | — | EP | disclosed |
| US-20250114441-A1 | POLYMERIC VACCINE FOR OPIOID ADDICTION | THE JOHNS HOPKINS UNVERSITY | 2025-04-10 | — | — | US | disclosed |
| WO-2024040169-A2 | METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS | THE UNIVERSITY OF CHICAGO (US) | 2024-02-22 | — | — | WO | disclosed |
| WO-2024015963-A2 | BIFUNCTIONAL PHOTOCROSSLINKING PROBES FOR COVALENT CAPTURE OF PROTEIN-NUCLEIC ACID COMPLEXES IN CELLS | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2024-01-18 | — | — | WO | disclosed |
| US-11484599-B2 | Polymer conjugate vaccines | THE UNIVERSITY OF CHICAGO (US) | 2022-11-01 | — | — | US | disclosed |
| CN-108770357-B | Polymer conjugate vaccines | 芝加哥大学 | 2022-10-28 | — | — | CN | disclosed |
| WO-2022200542-A1 | FLAVONOID POLYAMINES AND THEIR USE TREATING CENTRAL NERVOUS SYSTEM DISORDERS | Floratek Pharma SA (CH) | 2022-09-29 | — | — | WO | disclosed |
| WO-2022200541-A1 | HETEROCYCLIC SUBSTITUTED POLYAMINE COMPOUNDS HAVING NEUROPROTECTIVE ACTIVITY | Floratek Pharma SA (CH) | 2022-09-29 | — | — | WO | disclosed |
| US-20020151070-A1 | Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy | BISCHOFF RAINER (SE) | 2002-10-17 | — | — | US | disclosed |
| US-6335199-B1 | GENE THERAPY | TRANSGENE S.A. (FR) | 2002-01-01 | — | — | US | disclosed |
| US-5476870-A | Immunosuppressants | FOURNIER INDUSTRIE ET SANTE (FR) | 1995-12-19 | — | — | US | disclosed |
| US-4983328-A | ANTITUMOR AGENTS | BRISTOL-MYERS COMPANY (US) | 1991-01-08 | — | — | US | disclosed |
| EP-0117501-B1 | A PROCESS FOR THE PREPARATION OF 1,5-DIPROTECTED-1,5,10-TRIAZADECANE, INTERMEDIATES THEREOF AND THEIR PREPARATION | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1988-04-06 | — | — | EP | disclosed |
| US-4529549-A | Compound containing guanidine and amino groups | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1985-07-16 | — | — | US | disclosed |
| US-4518532-A | ANTITIMOR | ZAIDAN HOJIN BISEIBUTSU KAGAKU KENKYU KAI (JP) | 1985-05-21 | — | — | US | disclosed |
| EP-0117501-A1 | A process for the preparation of 1,5-diprotected-1,5,10-triazadecane, intermediates thereof and their preparation | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1984-09-05 | — | — | EP | disclosed |
| EP-0105193-A2 | Spergualin-related compounds, processes for the preparation thereof and their use as medicaments | MICROBIAL CHEMISTRY RESEARCH FOUNDATION (JP) | 1984-04-11 | — | — | EP | disclosed |
| US-4430346-A | N-(4-(3-AMINOPROPYL)AMINOBUTYL)-2-(CS)-7-GUANIDINO-3 -HYDROXYHEPTANAMIDE)-2-HYDROXYETHANAMIDE, ESTERS, AMIDATION ACID CATALYST | BRISTOL-MYERS COMPANY (US) | 1984-02-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11484599-B2 | Polymer conjugate vaccines | CD14, TLR3, TLR1 | CA14 2134/4885TDP1 4171/4885MAOA 3791/4885 |
| US-20250388597-A1 | BIFUNCTIONAL PHOTOCROSSLINKING PROBES FOR COVALENT CAPTURE OF PROTEIN-NUCLEIC ACID COMPLEXES IN CELLS | PCNA, DDB1, DCLRE1A | CA14 4520/4885TDP1 1256/4885MAOA 4411/4885 |
| US-20020151070-A1 | Lipid compounds and compositions containing them which can be used for the transfer of at least one active substance, in particular a polynucleotide, into a target cell and use in gene therapy | POLRMT, POLM, POLN | CA14 3668/4885TDP1 2269/4885MAOA 3933/4885 |
| US-20250114441-A1 | POLYMERIC VACCINE FOR OPIOID ADDICTION | OPRM1, OPRK1, OPRL1 | CA14 3516/4885TDP1 4498/4885MAOA 981/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.